Business Context and Reporting Period
Clover Health Investments, Corp. filed a Form 8-K regarding a management change under Item 5.02. The filing identifies July 9, 2021 as the date of the earliest reported event, while the announcement and signature date shown in the filing are July 15, 2021. No financial reporting period or operating results are presented.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes
- Chief Financial Officer Joseph Wagner will step down effective August 13, 2021, following the filing of the quarterly report for the quarter ended June 30, 2021.
- The company stated that Mr. Wagner’s departure is for personal reasons and does not reflect disagreement with the company’s operations, policies, or practices.
- Clover Health has begun searching for a permanent CFO.
- Mark Herbers joined as interim Senior Vice President of Finance and will become interim CFO on August 13, 2021, serving until a permanent replacement is appointed.
Outlook, Risks, and Unusual Items
The filing provides no financial guidance or operating outlook. The CFO transition may create execution and reporting-continuity considerations, although management described the arrangement as intended to support a smooth transition. Mr. Herbers has prior interim CFO and healthcare-sector experience. No contingencies or unusual financial items are disclosed.
Investor Verification Points
- Verify the timing of Mr. Wagner’s departure and the filing of the June 30, 2021 Form 10-Q.
- Monitor the appointment and qualifications of the permanent CFO.
- Review subsequent filings for any changes to financial results, liquidity, controls, or guidance during the CFO transition.
- Reconcile the filing’s July 9 earliest-event date with the July 15 announcement and filing dates.